Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company based in South San Francisco, California. They are focused on developing next-generation CART therapies and off-the-shelf allogeneic T-cell immunotherapy for cancer, multiple sclerosis, Epstein-Barr virus-positive post-transplant lymphoproliferative disorder (PTLD), and cell therapy. Atara Biotherapeutics harnesses the natural biology of T cells to fight against diseases.

Atara Biotherapeutics, Inc. Vice President Technical Operations. South San Francisco, California. Genentech, profile picture.

Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx #immunotherapy for cancer & #MS #EBV+ #PTLD #celltherapy.

Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf ...

Atara Biotherapeutics

Find contacts at this company